Phosphorodiamidate morpholino oligonucleotide FM10, which targets the polyadenylation signal, reduced DUX4 protein levels without significant cell toxicity and overt off-target effects in both FSHD myogenic cells and human muscle xenografts [126]. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.